Aripiprazole N-Isomer | CAS 1797983-65-3 - Request Quote
Aripiprazole N-Isomer
| SZ CAT No: | SZ-A001021 |
| CAS No | 1797983-65-3 |
| Mol.F. | C23H27Cl2N3O2 |
| Mol.Wt. | 448.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Aripiprazole N-Isomer is chemically 1-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-7-hydroxy-3,4-dihydro quinolin-2(1H)-one. Aripiprazole N-Isomer is supplied with detailed characterization data compliant with regulatory guideline. Aripiprazole N-Isomer can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Aripiprazole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1797983-65-3
Purchase 1797983-65-3
Order 1797983-65-3
Enquire 1797983-65-3
price of 1797983-65-3
1797983-65-3 Supplier
1797983-65-3 Manufacturer
1797983-65-3 Exporter
buy high quality Aripiprazole N-Isomer
Purchase Aripiprazole N-Isomer
Aripiprazole N-Isomer suppliers
Aripiprazole N-Isomer manufacturers
Aripiprazole N-Isomer price
Order Aripiprazole N-Isomer
Enquire Aripiprazole N-Isomer
Aripiprazole N-Isomer cost
Aripiprazole N-Isomer Supplier
Aripiprazole N-Isomer Distributor
Aripiprazole N-Isomer for Method Validation
Aripiprazole Reference Standard
Aripiprazole N-Isomer for ANDA Filing
Aripiprazole N-Isomer for Forced Degradation Studies
Aripiprazole N-Isomer Identification Standards
Aripiprazole N-Isomer for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.